222 related articles for article (PubMed ID: 8639672)
21. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
Tanner JJ; Komissarov AA; Deutscher SL
J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
[TBL] [Abstract][Full Text] [Related]
22. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
23. X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
Eigenbrot C; Gonzalez T; Mayeda J; Carter P; Werther W; Hotaling T; Fox J; Kessler J
Proteins; 1994 Jan; 18(1):49-62. PubMed ID: 7908437
[TBL] [Abstract][Full Text] [Related]
24. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
[TBL] [Abstract][Full Text] [Related]
25. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
Dick LW; Qiu D; Cheng KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766
[TBL] [Abstract][Full Text] [Related]
26. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of an anti-anti-idiotype shows it to be self-complementary.
Ban N; Day J; Wang X; Ferrone S; McPherson A
J Mol Biol; 1996 Feb; 255(4):617-27. PubMed ID: 8568901
[TBL] [Abstract][Full Text] [Related]
29. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
30. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
Mouratou B; Stetefeld J
Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
Mylvaganam SE; Paterson Y; Getzoff ED
J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
[TBL] [Abstract][Full Text] [Related]
35. Knowledge-based design of reagentless fluorescent biosensors from recombinant antibodies.
Renard M; Belkadi L; Hugo N; England P; Altschuh D; Bedouelle H
J Mol Biol; 2002 Apr; 318(2):429-42. PubMed ID: 12051849
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
[TBL] [Abstract][Full Text] [Related]
38. Crystallization and preliminary X-ray diffraction study of an idiotope-anti-idiotope Fv-Fv complex.
Goldbaum FA; Fields BA; Cauerhff A; Ysern X; Houdusse A; Eisele JL; Poljak RJ; Mariuzza RA
J Mol Biol; 1994 Sep; 241(5):739-43. PubMed ID: 8071997
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
[TBL] [Abstract][Full Text] [Related]
40. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity.
Rehder DS; Chelius D; McAuley A; Dillon TM; Xiao G; Crouse-Zeineddini J; Vardanyan L; Perico N; Mukku V; Brems DN; Matsumura M; Bondarenko PV
Biochemistry; 2008 Feb; 47(8):2518-30. PubMed ID: 18232715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
